Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Seminars in Immunopathology|May 31, 2022
Immuno-pathogenesis of neuromyelitis optica and emerging therapiesNorio Chihara, Takashi Yamamura
Immunological Medicine|August 30, 2019
Plasmablasts and neuroimmunological disordersNorio Chihara, Riki Matsumoto, Takashi Yamamura
American Journal of Otolaryngology|June 8, 2012
Videofluorographic detection of anti-muscle-specific kinase-positive myasthenia gravisToshiyuki Yamamoto, Norio Chihara, Madoka Mori-Yoshimura, et al.
Rinsho Shinkeigaku = Clinical Neurology|March 11, 2008
[Low dose pergolide induced systemic edema and pleural effusion in a patient with Parkinson's disease]Norio Chihara, Mikito Hayakawa, Madoka Yoshimura, et al.
Current Protocols in Immunology|April 3, 2016
Differentiation and Characterization of Tr1 CellsNorio Chihara, Asaf Madi, Katarzyna Karwacz, et al.
Neurology and Therapy|April 24, 2026
Real-World Treatment Adherence and Persistence with C5 Inhibitor Therapy Versus Satralizumab in Patients with Neuromyelitis Optica Spectrum Disorder in JapanNorio Chihara, Justin Lee, Jeffrey C Yu, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 25, 2011
Variable phenotypes in a family with mitochondrial encephalomyopathy harboring a 3291T > C mutation in mitochondrial DNAYoko Sunami, Keizo Sugaya, Norio Chihara, et al.
Rinsho Shinkeigaku = Clinical Neurology|January 28, 2021
[A case of spinal cord infarction accompanied with neuromyelitis optica spectrum pathophysiology]Kimitaka Katanazaka, Norio Chihara, Sayaka Akazawa, et al.
Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia|April 28, 2021
Paraneoplastic Neuromyelitis Optica Spectrum Disorder Associated with Atypical Thymic Carcinoid: A Case ReportSuguru Mitsui, Yugo Tanaka, Kenji Kimura, et al.
Rinsho Shinkeigaku = Clinical Neurology|July 26, 2019
[Increased disease activity in a case of multiple sclerosis after switching treatment from fingolimod to natalizumab]Ritsu Akatani, Norio Chihara, Kimitaka Katanazaka, et al.
Pageof 6